CN106727937A - It is a kind of to improve the health care of sleep Chinese medicine composition of state and preparation method thereof - Google Patents
It is a kind of to improve the health care of sleep Chinese medicine composition of state and preparation method thereof Download PDFInfo
- Publication number
- CN106727937A CN106727937A CN201710206265.0A CN201710206265A CN106727937A CN 106727937 A CN106727937 A CN 106727937A CN 201710206265 A CN201710206265 A CN 201710206265A CN 106727937 A CN106727937 A CN 106727937A
- Authority
- CN
- China
- Prior art keywords
- health care
- parts
- preparation
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000007958 sleep Effects 0.000 title claims abstract description 32
- 239000003814 drug Substances 0.000 title claims abstract description 27
- 239000000203 mixture Substances 0.000 title claims abstract description 25
- 230000036541 health Effects 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 241000237502 Ostreidae Species 0.000 claims abstract description 13
- 240000007164 Salvia officinalis Species 0.000 claims abstract description 13
- 235000020636 oyster Nutrition 0.000 claims abstract description 13
- 235000005412 red sage Nutrition 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 3
- 239000000706 filtrate Substances 0.000 claims description 26
- 239000003960 organic solvent Substances 0.000 claims description 18
- 239000000341 volatile oil Substances 0.000 claims description 17
- 238000001914 filtration Methods 0.000 claims description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 6
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 6
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 6
- 235000013339 cereals Nutrition 0.000 claims description 5
- 239000012467 final product Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 235000020985 whole grains Nutrition 0.000 claims description 5
- 239000000853 adhesive Substances 0.000 claims description 3
- 230000001070 adhesive effect Effects 0.000 claims description 3
- 239000003085 diluting agent Substances 0.000 claims description 3
- 239000007884 disintegrant Substances 0.000 claims description 3
- 235000003599 food sweetener Nutrition 0.000 claims description 3
- 239000000314 lubricant Substances 0.000 claims description 3
- 239000003381 stabilizer Substances 0.000 claims description 3
- 239000003765 sweetening agent Substances 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- 230000002335 preservative effect Effects 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 241000196324 Embryophyta Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 14
- 230000007774 longterm Effects 0.000 abstract description 5
- 238000005516 engineering process Methods 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 229940126678 chinese medicines Drugs 0.000 abstract description 2
- 238000009776 industrial production Methods 0.000 abstract 1
- 208000019116 sleep disease Diseases 0.000 description 9
- 208000020685 sleep-wake disease Diseases 0.000 description 9
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 208000011580 syndromic disease Diseases 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 7
- 238000009826 distribution Methods 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000002618 waking effect Effects 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 208000000224 Night Terrors Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 206010041010 Sleep terror Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000005059 dormancy Effects 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 229960002748 norepinephrine Drugs 0.000 description 2
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 2
- -1 polyethylene Polymers 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000036385 rapid eye movement (rem) sleep Effects 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 description 1
- LDCYZAJDBXYCGN-VIFPVBQESA-N 5-hydroxy-L-tryptophan Chemical compound C1=C(O)C=C2C(C[C@H](N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-VIFPVBQESA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 208000007590 Disorders of Excessive Somnolence Diseases 0.000 description 1
- 206010052804 Drug tolerance Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010054949 Metaplasia Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000005439 Sleep paralysis Diseases 0.000 description 1
- 206010041347 Somnambulism Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- KJADKKWYZYXHBB-XBWDGYHZSA-N Topiramic acid Chemical compound C1O[C@@]2(COS(N)(=O)=O)OC(C)(C)O[C@H]2[C@@H]2OC(C)(C)O[C@@H]21 KJADKKWYZYXHBB-XBWDGYHZSA-N 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 239000003420 antiserotonin agent Substances 0.000 description 1
- 210000003445 biliary tract Anatomy 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000133 brain stem Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 229940084030 carboxymethylcellulose calcium Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- CDCHDCWJMGXXRH-UHFFFAOYSA-N estazolam Chemical compound C=1C(Cl)=CC=C(N2C=NN=C2CN=2)C=1C=2C1=CC=CC=C1 CDCHDCWJMGXXRH-UHFFFAOYSA-N 0.000 description 1
- 229960002336 estazolam Drugs 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000026781 habituation Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 206010020765 hypersomnia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000015689 metaplastic ossification Effects 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical class COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000002182 neurohumoral effect Effects 0.000 description 1
- 230000009251 neurologic dysfunction Effects 0.000 description 1
- 208000015015 neurological dysfunction Diseases 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000008452 non REM sleep Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000003938 response to stress Effects 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 230000002295 serotoninergic effect Effects 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 229960004394 topiramate Drugs 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A61K35/10—Peat; Amber; Turf; Humus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
It is specifically a kind of to improve the health care of sleep Chinese medicine composition of state and preparation method thereof the present invention relates to the field of Chinese medicines.It is characterized in that being made up of the raw material of following portions by weight：6~12 parts of amber, 9~15 parts of mother-of-pearl, 9~15 parts of Os Draconis, 9~15 parts of raw oyster, 20~40 parts of the red sage root.Compared with the existing technology, simple production process, low production cost, implementation are strong, it is easy to large-scale industrial production for the present invention；The Chinese medicine being compounded to form by amber, mother-of-pearl, Os Draconis, raw oyster, red sage root etc. has significant curative effect for improving the health care of sleep state, and for improving the health care of sleep state effect is significant, Small side effects can long-term taking；Dose is small simultaneously, convenient to take, and can preferably ensure medicine stability and effect.
Description
Technical field
The present invention relates to the field of Chinese medicines, specifically a kind of Chinese medicine composition for improving the health care of sleep state and its preparation side
Method.
Background technology
Sleep-disorder syndrome is one group drops to the clinical common disease of main performance with sleep quality, with diet because
The factor such as element, environmental factor, disease, pressure is excessive is relevant, is apt to occur in the crowd of all age group.Patient is mainly shown as mistake
Dormancy, sleep paralysis, the symptoms such as preceding illusion, difficulty falling asleep, sleep-walking, sometimes sleeping and sometimes waking, Periodic leg movements are slept, had a strong impact on the normal of patient
Life, influences normal operating efficiency.Sleep-disorder syndrome has that the incidence of disease is high, disease time is long, recurrent exerbation the characteristics of.It is long
The patient that there is sleep-disorder phase easily triggers the complication such as neurological dysfunction, digestive function exception, physical dysfunction, reduces
Immunity of organisms, influences the physical and mental health of patient.Doctor trained in Western medicine is mainly treated using tranquilizing and allaying excitement class medicine, but long-term taking
There is dependence, the danger with habituation, abuse and excess, being excessively used Central nervous has damage, influences therapeutic effect, no
Suggestion long-term taking Western medicine drug.
Modern Chinese medicine thinks that sleep-disorder syndrome is the volt abnormal aggregation of the cause of fire, after effect body Mucosal system, especially
Small intestine and biliary tract mucous membrane, cause organism endocrine exception, disturb stress response system, cause " Neuro-endocrine-immunity " to regulate and control disorderly
Disorderly, one group of metabolic disorder syndrome of sleep center aberrant electrical signals is triggered.
This new knowledge highlights " volt the cause of fire son " and " body Mucosal system ", this be cause sleep-disorder syndrome at the beginning of
Beginning condition and reason.From this understanding, we can just shoot the arrow at the target on sleep-disorder syndrome technology is prevented and treated, science,
Specification, system give more active treatment for sleep-disorder syndrome.
Have confirmed now, brain stem tail end has very important relation with sleep, it is considered to be the place of sleep center.This
The various excitant lesions in position cause hypersomnia, and destructive lesion causes sleep to reduce.It has further been found that in having during sleep
The neurohumoral participation of pivot, stimulates serotoninergic neuron or injection 5-HTP, can produce nonrapid eye movement sleep, and
To Serotonin Antagonist, sleep is produced to reduce.Using norepinephrine antagonistic, then rapid eye movement sleep is reduced, and is given
Norepinephrine excitomotor, rapid eye movement sleep increases.
The content of the invention
The present invention is to overcome the deficiencies in the prior art, there is provided a kind of Chinese medicine composition, and it is used to improve the health care of sleep state effect
Fruit significantly, Small side effects, can long-term taking, and the Chinese medicine composition dose is small, convenient to take, and can preferably protect
Card medicine stability and effect.
To achieve the above object, a kind of Chinese medicine composition for improving the health care of sleep state is designed, it is characterised in that by following weight
The raw material of number is made：6~12 parts of amber, 9~15 parts of mother-of-pearl, 9~15 parts of Os Draconis, 9~15 parts of raw oyster, the red sage root 20~
40 parts.
The amber, mother-of-pearl, Os Draconis, raw oyster and the red sage root are its water extract or extractive with organic solvent.
A kind of preparation method of the Chinese medicine composition for improving the health care of sleep state as claimed in claim 1, it is characterised in that bag
Include following preparation process：
1）Step 1, takes amber, the red sage root of above-mentioned parts by weight, soaks 0.5~1 hour, is then heated to reflux 2~3 times,
1~3 hour every time, volatile oil is collected, volatile oil adds microcrystalline cellulose, be well mixed, obtain volatile oil figuration powder, liquid is while hot
Filtering, filtrate merges, and obtains a filtrate；
2）Step 2, takes mother-of-pearl, Os Draconis, the raw oyster of above-mentioned percentage by weight, then adds water to cook 2 times, first time 0.5
~2 hours, second 1~3 hour, filtration obtained No. two filtrates；
3）Step 3, merges a filtrate and No. two filtrates, with organic solvent filtering and concentrating, organic solvent is reclaimed, 25 DEG C~60
It is condensed into thick paste in the case of DEG C, drying under reduced pressure is crushed, and is subsequently adding volatile oil figuration powder and auxiliary material, is mixed, is made
Grain, dries, whole grain, and packaging obtains final product Chinese medicinal composition preparation.
Organic solvent in the step 3 is ethanol, organic solvent concentration condition for be concentrated into relative density for 1.08~
1.28, add ethanol to make the alcohol content of organic solvent be 50~70%.
Diluent, lubricant, adhesive, disintegrant, sweetener, stabilizer, anti-is added in the Chinese medicinal composition preparation
One or more mixture in rotten agent etc..
Described Chinese medicinal composition preparation is the one kind in pulvis, tablet, granule, capsule, soft capsule, spray.
Compared with the existing technology, simple production process, low production cost, implementation are strong, it is easy to large-scale industry for the present invention
Metaplasia is produced；The Chinese medicine being compounded to form by amber, mother-of-pearl, Os Draconis, raw oyster, red sage root etc. for improve the health care of sleep state have it is aobvious
The curative effect of work, for improving the health care of sleep state effect is significant, Small side effects can long-term taking；Dose is small simultaneously, convenient to take,
And can preferably ensure medicine stability and effect.
Specific embodiment
The property of medicine and pharmacology of the medicine selected by the present invention are respectively：
（1）Amber, meridian distribution of property and flavor：It is sweet, flat.The thoughts of returning home, liver, small intestine, bladder, lung, the spleen channel；Indication：Calmness, diuresis, promoting blood circulation.
For infantile convulsion, epilepsy, palpitaition, insomnia, difficult urination, odynuria, hematuria, amenorrhoea.
（2）Mother-of-pearl, meridian distribution of property and flavor：It is salty, cold.Return liver, the heart channel of Hang-Shaoyin；Indication：Soothing the liver, checking exuberance of yang, arresting convulsion, hemostasis.For
Dizzy, tinnitus, palpitaition, insomnia, demented, frightened epilepsy is spitted blood, bleeding from five sense organs or subcutaneous tissue, metrorrhagia
（3）Os Draconis, meridian distribution of property and flavor：It is sweet, puckery, flat, the thoughts of returning home, liver and kidney channel；Indication：Checking exuberant yang to ease mental strain, for hyperactivity of yang due to yin deficiency,
Irritable, palpitation and insomnia is had a dizzy spell, demented frightened grade disease
（4）Raw oyster, meridian distribution of property and flavor：It is salty, it is slightly cold.Return liver, courage, kidney channel；Indication：Calming the liver, transquilization with heavy material, softening hard masses dissipate
Knot, restrains astringent or styptic treatment for spontaneous sweating.For enriching yin, blood-nourishing, tonifying five zang organs, invigorate blood circulation, fill flesh etc..
（5）The red sage root, meridian distribution of property and flavor：It is bitter, be slightly cold.The thoughts of returning home, Liver Channel；Indication：Promoting blood circulation, it is inducing meastruation to relieve menalgia, clear away heart-fire and remove
It is tired, cool blood to disappear carbuncle.For chest impediment and cardialgia, gastral cavity abdomen hypochondriac pain, the accumulation of lump in the abdomen lump in the abdomen, hot numbness pain, dysphoria and insomnia, irregular menstruation, dysmenorrhoea warp
Close, sore swell and ache curative.
Heretofore described diluent includes but is not limited to lactose, starch, microcrystalline cellulose, mannitol etc.；Described
Lubricant includes but is not limited to magnesium stearate, talcum powder etc.；Described adhesive includes but is not limited to polyethylene Topiramate Los oxazolidinone, hydroxyl
Propyl cellulose etc.；Described disintegrant includes but is not limited to carboxymethylcellulose calcium, acetic acid carboxy starch sodium, PVPP
Deng；Described sweetener includes but is not limited to sucrose, fructose, D-sorbite etc.；Described stabilizer includes but is not limited to carboxylic first
Base sodium cellulosate, cyclodextrin, xanthans etc.；Described preservative includes but is not limited to potassium sorbate, nipagin esters etc..
Heretofore described method for concentration can be using the conventional method such as vacuum concentration or normal temperature be concentrated under reduced pressure.Drying side
Method can be using conventional methods such as spray drying or freeze-dryings.The method that filtrate and residue are separate can using filtering or
The conventional methods such as person's centrifugation.
Embodiment one：
Amber 6g, red sage root 20g are taken first, 0.5 hour is soaked and then is heated to reflux 3 times, 3 hours every time, collect volatilization
Oil, volatile oil adds microcrystalline cellulose, is well mixed, and obtains volatile oil figuration powder, and liquid is filtered while hot, and filtrate merges, and obtains No. one
Filtrate.
Mother-of-pearl 9g, Os Draconis 9g, raw oyster 9g then are weighed, is then added water to cook 2 times, for the first time 0.5 hour, second
Secondary 1.5 hours, filtration obtained No. two filtrates.
Finally a filtrate and No. two filtrates are merged, with organic solvent filtering and concentrating, organic solvent is reclaimed, 25 DEG C~
It is condensed into thick paste in the case of 60 DEG C, drying under reduced pressure is crushed, and is subsequently adding volatile oil figuration powder and auxiliary material, is mixed, is made
Grain, dries, whole grain, and packaging obtains final product Chinese medicinal composition preparation.
The present embodiment is used to improve the health care of sleep state.Orally, one time 10~20 grams every time（1~3 bag）, daily 1~3 time.
Embodiment two：
Amber 9g, red sage root 30g are taken, 1 hour is soaked and then is heated to reflux 2 times, 1.5 hours every time, collect volatile oil, volatilization
Oil plus microcrystalline cellulose, are well mixed, and obtain volatile oil figuration powder, and liquid is filtered while hot, and filtrate merges, and obtains a filtrate.
Mother-of-pearl 12g, Os Draconis 12g, raw oyster 12g then are weighed, is then added water to cook 2 times, 1 hour for the first time, the
Secondary 2 hours, filtration obtained No. two filtrates.
Finally a filtrate and No. two filtrates are merged, with organic solvent filtering and concentrating, organic solvent is reclaimed, 25 DEG C~
It is condensed into thick paste in the case of 60 DEG C, drying under reduced pressure is crushed, and is subsequently adding volatile oil figuration powder and auxiliary material, is mixed, is made
Grain, dries, whole grain, and packaging obtains final product Chinese medicinal composition preparation.
The present embodiment is used to improve the health care of sleep state.Orally, one time 10~20 grams every time（1~3 bag）, daily 1~3 time.
Embodiment three：
Amber 12g, red sage root 40g are taken, 1 hour is soaked and then is heated to reflux 3 times, 2 hours every time, collect volatile oil, volatilization
Oil plus microcrystalline cellulose, are well mixed, and obtain volatile oil figuration powder, and liquid is filtered while hot, and filtrate merges, and obtains a filtrate.
Mother-of-pearl 15g, Os Draconis 15g, raw oyster 15g then are weighed, is then added water to cook 2 times, 1 hour for the first time, the
Secondary 3 hours, filtration obtained No. two filtrates.
Finally a filtrate and No. two filtrates are merged, with organic solvent filtering and concentrating, organic solvent is reclaimed, 25 DEG C~
It is condensed into thick paste in the case of 60 DEG C, drying under reduced pressure is crushed, and is subsequently adding volatile oil figuration powder and auxiliary material, is mixed, is made
Grain, dries, whole grain, and packaging obtains final product Chinese medicinal composition preparation.
The present embodiment is used to improve the health care of sleep state.Orally, one time 10~20 grams every time（1~3 bag）, daily 1~3 time.
Model case：
80 patients for being diagnosed as sleep-disorder person are selected, MethodsThe cases enrolled is divided into treatment group and control group by random digits table, its
Middle treatment group 40, man 17, female 23；18~65 years old age, average 46.4 years old；The course of disease 2 months~3.5 years.Control group 40
Example, man 19, female 21；19~64 years old age, average 48.9 years old；The course of disease 1.5 months~3 years.And two groups of patients the age,
The physical data such as sex, course of disease comparing difference is without significant, P ＞ 0.05, with comparativity.
During treatment, the alone estazolam piece treatment of control group, daily 1~2mg sleeps first 30 minutes orally, is within 14 days 1 treatment
Journey.Take 2 courses for the treatment of.The oral present invention for the treatment of group according to particle obtained in specific embodiment 1, take after mixing it with water by boiling water, one time 10~
20 grams（1~3 bag）, daily 1~3 time, course for the treatment of 7 days.Take 4 courses for the treatment of.
| Group | n | Cure | Take a turn for the better | It is invalid | Total effective rate | Adverse reaction example |
| Control group | 40 | 7（17.5%） | 19（47.5%） | 14（35.0%） | 26（65.0%） | 0 |
| Treatment group | 40 | 21（52.5%） | 15（37.5%） | 4（10.0%） | 36（90.0%） | 20 |
Upper table is the comparitive study after the two groups of patients treatment with sleep-disorder syndrome, wherein the therapeutic evaluation cured
Standard be difficulty falling asleep, sleep terror fright at night, dreaminess, it is shallow sleep easily wake up etc. symptom substantially eliminate, length of one's sleep night reaches more than 5 hours, sleeps
Dormancy quality is good, hale and hearty after waking up；The standard of curative effect evaluation of improvement be difficulty falling asleep, sleep terror fright at night, dreaminess, it is shallow sleep easily wake up etc. symptom it is bright
Aobvious to alleviate, length of one's sleep night reaches more than 3 hours, but occasionally has difficulty falling asleep, dreaming often and waking easily, and spiritedness is tired, mental after waking up
The symptom such as blunt；Invalid the standard of curative effect evaluation is that symptom is same treats preceding thing notable difference.
Statistical procedures are carried out using the statistical softwares of SPSS 15.0, measurement data is checked using t, and enumeration data is used
χ2Inspection, is that difference is statistically significant with P ＜ 0.05.
From upper table, control group total effective rate compares P ﹤ 0.05 with treatment group.
Understand that the present invention can safely and effectively improve the health care of sleep state.
Claims (6)
1. a kind of Chinese medicine composition for improving the health care of sleep state, it is characterised in that be made up of the raw material of following portions by weight：Amber 6~
12 parts, 9~15 parts of mother-of-pearl, 9~15 parts of Os Draconis, 9~15 parts of raw oyster, 20~40 parts of the red sage root.
2. a kind of Chinese medicine composition for improving the health care of sleep state as claimed in claim 1, it is characterised in that：The amber, pearl
Mother, Os Draconis, raw oyster and the red sage root are its water extract or extractive with organic solvent.
3. a kind of preparation method of the as claimed in claim 1 Chinese medicine composition for improving the health care of sleep state, it is characterised in that including
Following preparation process：
1）Step 1, takes amber, the red sage root of above-mentioned parts by weight, soaks 0.5~1 hour, is then heated to reflux 2~3 times,
1~3 hour every time, volatile oil is collected, volatile oil adds microcrystalline cellulose, be well mixed, obtain volatile oil figuration powder, liquid is while hot
Filtering, filtrate merges, and obtains a filtrate；
2）Step 2, takes mother-of-pearl, Os Draconis, the raw oyster of above-mentioned percentage by weight, then adds water to cook 2 times, first time 0.5
~2 hours, second 1~3 hour, filtration obtained No. two filtrates；
3）Step 3, merges a filtrate and No. two filtrates, with organic solvent filtering and concentrating, organic solvent is reclaimed, 25 DEG C~60
It is condensed into thick paste in the case of DEG C, drying under reduced pressure is crushed, and is subsequently adding volatile oil figuration powder and auxiliary material, is mixed, is made
Grain, dries, whole grain, and packaging obtains final product Chinese medicinal composition preparation.
4. a kind of preparation method of the Chinese medicine composition for improving the health care of sleep state as claimed in claim 3, it is characterised in that：It is described
Organic solvent in step 3 is ethanol, and organic solvent concentration condition is 1.08~1.28 to be concentrated into relative density, adds ethanol
The alcohol content for making organic solvent is 50~70%.
5. a kind of preparation method of the Chinese medicine composition for improving the health care of sleep state as claimed in claim 3, it is characterised in that：It is described
One in diluent, lubricant, adhesive, disintegrant, sweetener, stabilizer, preservative etc. is added in Chinese medicinal composition preparation
Plant or more than one mixture.
6. a kind of preparation method of the Chinese medicine composition for treating osteocarcinoma as claimed in claim 3, it is characterised in that：In described
Drug composition preparation is the one kind in pulvis, tablet, granule, capsule, soft capsule, spray.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710206265.0A CN106727937A (en) | 2017-03-31 | 2017-03-31 | It is a kind of to improve the health care of sleep Chinese medicine composition of state and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710206265.0A CN106727937A (en) | 2017-03-31 | 2017-03-31 | It is a kind of to improve the health care of sleep Chinese medicine composition of state and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106727937A true CN106727937A (en) | 2017-05-31 |
Family
ID=58965732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710206265.0A Withdrawn CN106727937A (en) | 2017-03-31 | 2017-03-31 | It is a kind of to improve the health care of sleep Chinese medicine composition of state and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106727937A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112617548A (en) * | 2020-12-25 | 2021-04-09 | 海南娜古芳沉香科技有限公司 | Kyara extract for preparing latex pillow for improving sleep, preparation method and latex pillow prepared from Kyara extract |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101199701A (en) * | 2007-11-17 | 2008-06-18 | 刘占红 | Chinese medicine for treating insomnia and preparing method thereof |
| CN101491625A (en) * | 2009-02-11 | 2009-07-29 | 陆小左 | Sedative anti-insomnia oral medicine |
| CN101642540A (en) * | 2009-06-14 | 2010-02-10 | 李承平 | Chinese patent medicine for tranquilizing and allaying excitement |
| CN102526546A (en) * | 2012-01-04 | 2012-07-04 | 田胜利 | Chinese medicinal composition and preparation and preparation method thereof |
| CN104225501A (en) * | 2014-10-09 | 2014-12-24 | 马俊安 | Traditional Chinese medicine for treating cardiac neurosis and preparation method thereof |
| CN104825800A (en) * | 2015-05-27 | 2015-08-12 | 东阿阿胶股份有限公司 | Medicine for treating insomnia and method for manufacturing medicine |
-
2017
- 2017-03-31 CN CN201710206265.0A patent/CN106727937A/en not_active Withdrawn
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101199701A (en) * | 2007-11-17 | 2008-06-18 | 刘占红 | Chinese medicine for treating insomnia and preparing method thereof |
| CN101491625A (en) * | 2009-02-11 | 2009-07-29 | 陆小左 | Sedative anti-insomnia oral medicine |
| CN101642540A (en) * | 2009-06-14 | 2010-02-10 | 李承平 | Chinese patent medicine for tranquilizing and allaying excitement |
| CN102526546A (en) * | 2012-01-04 | 2012-07-04 | 田胜利 | Chinese medicinal composition and preparation and preparation method thereof |
| CN104225501A (en) * | 2014-10-09 | 2014-12-24 | 马俊安 | Traditional Chinese medicine for treating cardiac neurosis and preparation method thereof |
| CN104825800A (en) * | 2015-05-27 | 2015-08-12 | 东阿阿胶股份有限公司 | Medicine for treating insomnia and method for manufacturing medicine |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112617548A (en) * | 2020-12-25 | 2021-04-09 | 海南娜古芳沉香科技有限公司 | Kyara extract for preparing latex pillow for improving sleep, preparation method and latex pillow prepared from Kyara extract |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104799116A (en) | Goat feed and preparation method thereof | |
| CN103520505A (en) | Traditional Chinese medicine preparation for treating neurasthenia and preparation method thereof | |
| CN104489265A (en) | Compound feed for treatment of moist fowl pox and preparation method thereof | |
| CN106727937A (en) | It is a kind of to improve the health care of sleep Chinese medicine composition of state and preparation method thereof | |
| CN105106440A (en) | Traditional Chinese medicine composition for treating headache and dizziness induced by lumbar anesthesia | |
| CN104799002A (en) | Feed additive for treating goat urolithiasis and preparation method thereof | |
| CN104800553B (en) | A kind of Chinese medicine composition for treating climacteric insomnia disease and preparation method thereof | |
| CN104147460A (en) | Traditional Chinese medicinal preparation for treating Parkinson's disease and preparation method thereof | |
| CN104336428A (en) | Health care product conducive to sleep | |
| CN104825800B (en) | A kind of medicine for the treatment of of insomnia patients and preparation method thereof | |
| CN104001057B (en) | For treating the heart schizoid medicine of kidney disorder type and preparation method thereof | |
| CN103520550B (en) | Traditional Chinese medicine for treating external cold internal rheum type chronic bronchitis and preparation method thereof | |
| CN104474045A (en) | Traditional Chinese medicine patch for treating febrile convulsion of infants and preparation method of traditional Chinese medicine patch | |
| CN105535587A (en) | Traditional Chinese medicinal preparation for treating heart and kidney disharmony type palpitation and insomnia and preparation method of traditional Chinese medicinal preparation | |
| CN104840794B (en) | A kind of Chinese medicine composition for treating senile insomnia and preparation method thereof | |
| CN104189496A (en) | Traditional Chinese medicine preparation for treating neurasthenia and preparation method thereof | |
| CN105055703A (en) | Anti-allergic traditional Chinese medicine composition and preparation method thereof | |
| CN107837331A (en) | A kind of Chinese medicine composition for treating insomnia and preparation method thereof | |
| CN107095977A (en) | A kind of medicament and its pharmaceutical formulation and preparation method with the malicious effect of fire row of dispelling | |
| CN104784393B (en) | A kind of Chinese goldthread colla corii asini composition for the treatment of of insomnia patients and preparation method thereof | |
| CN104258361A (en) | Traditional Chinese medicine composition for treating infantile asthma | |
| CN104127504B (en) | Infantile common cold cough syrup and preparation method thereof | |
| CN118436742A (en) | Traditional Chinese medicine composition with sedative hypnotic and insomnia treatment effects and preparation method thereof | |
| CN104173808B (en) | A kind of Chinese medicine and preparation method thereof for treating flaming-up of the liverfire type hypertension | |
| CN103690612B (en) | Chinese medicine composition for the treatment of severe pneumonia of infants and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170531 |